

Don't waste time calling every pharmacy. Learn how to check if Bacitracin/Polymyxin B ophthalmic ointment is in stock near you using online tools and apps.
You've got a prescription for Bacitracin/Polymyxin B ophthalmic ointment, and now your pharmacy tells you they don't have it. Sound familiar? With the ongoing bacitracin ophthalmic shortage, this has become a frustrating reality for many patients.
The last thing you want to do when you have a painful eye infection is spend an hour on the phone calling pharmacy after pharmacy. Here's how to check stock without picking up the phone.
Padagis (formerly Perrigo), one of the main manufacturers of bacitracin ophthalmic products, temporarily discontinued production of bacitracin ophthalmic ointment in July 2024. Resupply isn't expected until October 2026. This has created a ripple effect on combination products like Bacitracin/Polymyxin B ophthalmic ointment, making them harder to find at retail pharmacies.
The OTC topical form (Polysporin for skin) is generally not affected — it's the prescription ophthalmic version that's in short supply.
Medfinder is designed specifically for finding medications that are hard to get. Enter your medication name and zip code, and it shows you which pharmacies near you currently have Bacitracin/Polymyxin B ophthalmic ointment in stock. It's free to use and updates stock information regularly.
This is especially useful during shortages when pharmacy stock can change daily. Instead of guessing, you get a list of confirmed options.
Several major pharmacy chains let you check medication availability through their apps or websites:
Keep in mind that these apps may not show real-time inventory for every medication. During a shortage, stock can change quickly.
While GoodRx is primarily a price-comparison tool, it also shows you which pharmacies in your area carry a medication and what they charge. Search for "Bacitracin Polymyxin B ophthalmic" on GoodRx, enter your zip code, and you'll see a list of pharmacies with pricing. If a pharmacy lists a price, it's a good indication they carry the product (though they may not have it in stock at that moment).
Don't overlook independent pharmacies. They often have different suppliers than the big chains and may have stock when CVS and Walgreens don't. Many independent pharmacies also offer more personalized service and can work harder to source hard-to-find medications for you.
To find independent pharmacies near you, search "independent pharmacy near me" on Google Maps, or check the NCPA (National Community Pharmacists Association) directory.
If no retail pharmacy near you has Bacitracin/Polymyxin B, a compounding pharmacy may be able to prepare it for you. Compounding pharmacies make custom medications using individual ingredients. The cost may be higher, but it's an option when commercial products are unavailable.
Your doctor may need to write a specific compounding prescription. Ask them about this option if you've struck out everywhere else.
Sometimes a quick phone call is the most direct route. Here are tips to make it efficient:
When you've located a pharmacy with Bacitracin/Polymyxin B in stock:
Finding Bacitracin/Polymyxin B ophthalmic ointment in 2026 takes a little more effort than usual thanks to the ongoing manufacturing disruption. But you don't have to call a dozen pharmacies — tools like Medfinder make it possible to check stock from your phone in seconds.
If the ophthalmic ointment is truly unavailable in your area, talk to your doctor about alternative antibiotics that can treat your eye infection effectively. The most important thing is getting treatment started — don't let a stock issue delay your care.
You focus on staying healthy. We'll handle the rest.
Try Medfinder Concierge FreeMedfinder's mission is to ensure every patient gets access to the medications they need. We believe this begins with trustworthy information. Our core values guide everything we do, including the standards that shape the accuracy, transparency, and quality of our content. We’re committed to delivering information that’s evidence-based, regularly updated, and easy to understand. For more details on our editorial process, see here.